Karyopharm Therapeutics Inc
NASDAQ:KPTI 4:00:00 PM EDT
| Market Cap (Intraday) | 37.24M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $4.42 |
| 50-Day MA | $5.11 |
| 200-Day MA | $8.70 |
Karyopharm Therapeutics Inc Stock, NASDAQ:KPTI
85 Wells Avenue, Suite 210, 2nd floor, Newton, Massachusetts 02459-3298
United States of America
Phone: +1.617.658.0600
Number of Employees: 279
Description
Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A. DePinho, Pamela A, Silver, Giulio Draetta, Michael G. Kauffman, and Sharon Shacham on December 22, 2008, and is headquartered in Newton, MA.